Hyper-CVAD and sequential blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: a single-arm, single-centre, phase 2 trial

Authors: Elias Jabbour, Nicholas J. Short, Nitin Jain, Philip A. Thompson, Tapan M. Kadia, Alessandra Ferrajoli, Xuelin Huang, Musa Yılmaz, Yesid Alvarado, Keyur P. Patel, Guillermo Garcia‐Manero, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop M. Kantarjian - The Lancet 2022 cited by 82